• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几丁质衍生物的抗高血压活性。

Antihypertensive activity of chitin derivatives.

作者信息

Je Jae-Young, Park Pyo-Jam, Kim Bokyung, Kim Se-Kwon

机构信息

Department of Chemistry, Pukyong National University, Busan 608-737, Korea.

出版信息

Biopolymers. 2006 Oct 15;83(3):250-4. doi: 10.1002/bip.20553.

DOI:10.1002/bip.20553
PMID:16763977
Abstract

To develop angiotensin I converting enzyme (ACE) inhibitory chitin derivatives based on the properties of ACE inhibitors, chitins with different degree of deacetylation were chemically modified by grafting 2-chloroethylamino hydrochloride onto chitin at the C-6 position. Three kinds of chitin derivatives were prepared and designated as aminoethyl-chitin (AEC) with 10% degree of deacetylation, aminoethyl-chitin with 50% degree of deacetylation (AEC50), and aminoethyl-chitin with 90% degree of deacetylation (AEC90). IC50 values of three chitin derivatives on ACE were 0.064 microM (AEC), 0.038 microM (AEC50), and 0.103 microM (AEC90). The results of Dixon plots revealed that AEC50 was a competitive inhibitor, and the inhibition constant (Ki) value was 0.021 microM. In addition, the antihypertensive effect of AEC50 on spontaneously hypertensive rats (SHR) was evaluated, and the result showed that it effectively decreased systolic blood pressure (SBP) in a dose-dependent manner.

摘要

为了基于血管紧张素I转换酶(ACE)抑制剂的特性开发具有ACE抑制活性的几丁质衍生物,通过将2-氯乙胺盐酸盐接枝到不同脱乙酰度几丁质的C-6位进行化学修饰。制备了三种几丁质衍生物,分别命名为脱乙酰度为10%的氨乙基几丁质(AEC)、脱乙酰度为50%的氨乙基几丁质(AEC50)和脱乙酰度为90%的氨乙基几丁质(AEC90)。三种几丁质衍生物对ACE的IC50值分别为0.064微摩尔(AEC)、0.038微摩尔(AEC50)和0.103微摩尔(AEC90)。Dixon图结果显示AEC50是一种竞争性抑制剂,抑制常数(Ki)值为0.021微摩尔。此外,评估了AEC50对自发性高血压大鼠(SHR)的降压作用,结果表明它能有效降低收缩压(SBP),且呈剂量依赖性。

相似文献

1
Antihypertensive activity of chitin derivatives.几丁质衍生物的抗高血压活性。
Biopolymers. 2006 Oct 15;83(3):250-4. doi: 10.1002/bip.20553.
2
Renin inhibition activity by chitooligosaccharides.壳寡糖的肾素抑制活性。
Bioorg Med Chem Lett. 2008 Apr 1;18(7):2471-4. doi: 10.1016/j.bmcl.2008.02.041. Epub 2008 Feb 19.
3
Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.具有体外血管紧张素I转换酶抑制活性的大米蛋白水解物对自发性高血压大鼠的降压作用
Asia Pac J Clin Nutr. 2007;16 Suppl 1:275-80.
4
Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans.由部分不同脱乙酰壳多糖制备的杂合壳寡糖的血管紧张素I转化酶(ACE)抑制活性。
J Agric Food Chem. 2003 Aug 13;51(17):4930-4. doi: 10.1021/jf0340557.
5
Effect of angiotensin I-converting enzyme inhibitory peptide from rice dregs protein on antihypertensive activity in spontaneously hypertensive rats.米渣蛋白源血管紧张素I转换酶抑制肽对自发性高血压大鼠降压活性的影响。
Asia Pac J Clin Nutr. 2007;16 Suppl 1:281-5.
6
Synthesis of N-(phosphonoacetyl)-dipeptide derivatives and evaluation of their antihypertensive activity.N-(膦酰基乙酰基)-二肽衍生物的合成及其降压活性评估。
Pharmazie. 1990 Sep;45(9):666-8.
7
Antihypertensive effect of an angiotensin converting enzyme inhibitory peptide from enzyme modified cheese.酶解奶酪中血管紧张素转换酶抑制肽的降压作用
J Dairy Res. 2008 Aug;75(3):284-90. doi: 10.1017/S0022029908003452. Epub 2008 Jul 14.
8
Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.血管紧张素转换酶(ACE)抑制剂的心血管效应是否涉及不依赖ACE的机制?来自巴西矛头蝮富含脯氨酸肽的新见解。
J Pharmacol Exp Ther. 2007 Aug;322(2):795-805. doi: 10.1124/jpet.107.120873. Epub 2007 May 2.
9
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.二肽基肽酶IV抑制对动脉血压的影响。
Clin Exp Pharmacol Physiol. 2008 Jan;35(1):29-34. doi: 10.1111/j.1440-1681.2007.04737.x.
10
Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate.从小麦醇溶蛋白水解物中分离及鉴定血管紧张素I转换酶抑制肽
Nahrung. 2003 Oct;47(5):354-8. doi: 10.1002/food.200390081.

引用本文的文献

1
A Comprehensive Review on the Valorization of Bioactives from Marine Animal By-Products for Health-Promoting, Biofunctional Cosmetics.海洋动物副产品生物活性物质在促进健康的生物功能化妆品中的价值综合综述。
Mar Drugs. 2025 Jul 26;23(8):299. doi: 10.3390/md23080299.
2
Innovative Biomedical and Technological Strategies for the Control of Bacterial Growth and Infections.用于控制细菌生长和感染的创新生物医学与技术策略。
Biomedicines. 2024 Jan 13;12(1):176. doi: 10.3390/biomedicines12010176.
3
Symbiosal and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
共生作用与血压降低及高血压风险降低:依据欧盟第1924/2006号法规第14条对一项健康声明的评估
EFSA J. 2018 Jul 25;16(7):e05364. doi: 10.2903/j.efsa.2018.5364. eCollection 2018 Jul.
4
Tamarind Trypsin Inhibitor in Chitosan-Whey Protein Nanoparticles Reduces Fasting Blood Glucose Levels without Compromising Insulinemia: A Preclinical Study.罗望子胰蛋白酶抑制剂在壳聚糖-乳清蛋白纳米粒子中降低空腹血糖水平而不损害胰岛素血症:一项临床前研究。
Nutrients. 2019 Nov 14;11(11):2770. doi: 10.3390/nu11112770.
5
Vasoactive properties of keratin-derived compounds.角蛋白衍生化合物的血管活性特性。
Microcirculation. 2011 Nov;18(8):663-9. doi: 10.1111/j.1549-8719.2011.00135.x.
6
Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.海洋资源中的血管紧张素转化酶(ACE)抑制剂:在制药行业的前景。
Mar Drugs. 2010 Mar 31;8(4):1080-93. doi: 10.3390/md8041080.
7
NaCl plus chitosan as a dietary salt to prevent the development of hypertension in spontaneously hypertensive rats.氯化钠加壳聚糖作为膳食盐预防自发性高血压大鼠高血压的发展。
J Vet Sci. 2009 Jun;10(2):141-6. doi: 10.4142/jvs.2009.10.2.141.